+Compare
TAK
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
44.11B

TAK Takeda Pharmaceutical Company Limited Forecast, Technical & Fundamental Analysis

a pharmaceutical products manufacturer

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for TAK with price predictions
07:00 PM EST Dec 07, 2023

TAK's RSI Oscillator ascends from oversold territory

The RSI Indicator for TAK moved out of oversold territory on November 02, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where TAK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 07, 2023. You may want to consider a long position or call options on TAK as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TAK just turned positive on November 08, 2023. Looking at past instances where TAK's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TAK advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 239 cases where TAK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.928) is normal, around the industry mean (48.398). P/E Ratio (34.483) is within average values for comparable stocks, (60.542). Projected Growth (PEG Ratio) (0.928) is also within normal values, averaging (2.883). Dividend Yield (0.024) settles around the average of (0.027) among similar stocks. P/S Ratio (1.587) is also within normal values, averaging (66.055).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TAK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NASDAQ:ZTS), Teva Pharmaceutical Industries Limited (NASDAQ:TEVA), Elanco Animal Health (NASDAQ:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NASDAQ:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.78B. The market cap for tickers in the group ranges from 246 to 82.08B. ZTS holds the highest valuation in this group at 82.08B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -4%. UPC experienced the highest price growth at 58%, while CNTRF experienced the biggest fall at -75%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 68
Price Growth Rating: 61
SMR Rating: 84
Profit Risk Rating: 91
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

TAK is expected to report earnings to fall 193.44% to 9 cents per share on February 01

Takeda Pharmaceutical Company Limited TAK Stock Earnings Reports
Q4'23
Est.
$0.10
Q3'23
Missed
by $0.20
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.01
The last earnings report on October 26 showed earnings per share of -10 cents, missing the estimate of 9 cents. With 838.16K shares outstanding, the current market capitalization sits at 44.11B.
A.I.Advisor
published Dividends

TAK paid dividends on July 12, 2021

Takeda Pharmaceutical Company Limited TAK Stock Dividends
А dividend of $0.41 per share was paid with a record date of July 12, 2021, and an ex-dividend date of March 30, 2021. Read more...
A.I. Advisor
published General Information

General Information

a pharmaceutical products manufacturer

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1-1, Nihonbashi-Honcho 2-Chome
Phone
+81 332782306
Employees
49095
Web
https://www.takeda.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRDO18.210.38
+2.13%
Credo Technology Group Holding Ltd
DCO51.770.48
+0.94%
Ducommun
MKL1374.007.82
+0.57%
Markel Group
SEVN11.90-0.10
-0.83%
Seven Hills Realty Trust
FAZE0.20N/A
-1.94%
FaZe Holdings

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with RDY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then RDY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.14%
RDY - TAK
33%
Loosely correlated
-1.28%
SNOA - TAK
27%
Poorly correlated
-8.36%
HLN - TAK
25%
Poorly correlated
-0.36%
ZTS - TAK
25%
Poorly correlated
+1.52%
NLTX - TAK
25%
Poorly correlated
-1.25%
More

Groups containing TAK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.14%
pharmaceuticals
(undefined stocks)
26%
Poorly correlated
-0.20%
asia
(undefined stocks)
19%
Poorly correlated
+1.52%
Pharmaceuticals
(undefined stocks)
-4%
Poorly correlated
+0.75%
Pharmaceuticals: Other
(undefined stocks)
-4%
Poorly correlated
+0.96%